top of page

Press Releases

Ordinateur portable et paperasse

13 mai 2024

IMPLANET receives FDA clearance for its new hybrid fixation system Jazz Spinal System

25 avr. 2024

Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024

9 avr. 2024

IMPLANET reports its 2024 First-Quarter Revenue

6 mars 2024

IMPLANET reports its 2023 full-year results

2 févr. 2024

Implanet announces the success of its capital increase

25 janv. 2024

Implanet announces the appointment of Max W. Painter as Vice-President and General Manager of its US subsidiary

15 janv. 2024

IMPLANET reports 2023 annual revenue of €7.4 million

11 janv. 2024

IMPLANET announces its 2024 financial calendar

4 janv. 2024

Launch of an issue of new shares with preferential subscription rights

12 déc. 2023

IMPLANET announces the launch of its training program in advance of marketing its JAZZ® range in China

11 déc. 2023

Validation by Sanyou Medical's Board of Directors of its commitment to subscribe up to €5 million to IMPLANET's planned capital increase

16 nov. 2023

IMPLANET receives the approval of its shareholders for its planned capital increase

31 oct. 2023

IMPLANET specifies the terms of its planned capital increase

17 oct. 2023

IMPLANET announces its 3rd-quarter and 9-month revenue to September 30, 2023

11 oct. 2023

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

28 sept. 2023

IMPLANET signs an agreement with Sanyou Medical for a proposed capital increase with preferential subscription rights

28 sept. 2023

IMPLANET publishes its 2023 half-year results

11 juil. 2023

IMPLANET reports revenue of €4.3 million in the first half of 2023

4 mai 2023

Minutes of Implanet’s Annual General Meeting held on May 3, 2023

25 avr. 2023

IMPLANET reports its Q1 2023 revenue

11 avr. 2023

IMPLANET receives FDA clearance for its Squale anterior cervical cage range

7 mars 2023

IMPLANET reports its 2022 financial results

24 janv. 2023

IMPLANET reports 2022 annual revenue of €8.0 million, up 31%

14 déc. 2022

2023 Financial Calendar

28 nov. 2022

IMPLANET signs an exclusive distribution contract for SMTP Technology Co.'s ultrasonic surgical scalpel in France

16 nov. 2022

IMPLANET signs a distribution agreement with Sanyou Medical in China and a technological partnership for the development of a new product range

26 oct. 2022

IMPLANET announces 9-month revenue of €6 million as of September 30, 2022, up +37%

20 oct. 2022

Implanet announces the success of its capital increase

28 sept. 2022

Launch of an issue of shares with warrants with preferential subscription rights

20 sept. 2022

IMPLANET publishes its 2022 half-year results

20 sept. 2022

Partnership with Sanyou Medical: conditions precedent fulfilled

11 juil. 2022

IMPLANET reports its revenue for Q2 2022, up 33%

29 juin 2022

Implanet announces a commercial, technological and financial partnership with Sanyou Medical, a Chinese manufacturer of medical devices for spine surgery

19 avr. 2022

IMPLANET reports Q1 2022 revenue

15 mars 2022

IMPLANET reports its 2021 financial results and reviews its transformative year

22 févr. 2022

IMPLANET announces the first surgical operations in the United States with the ORIGIN cervical plate

10 févr. 2022

IMPLANET announces the first surgical procedures in the United States with JAZZ PF

27 janv. 2022

IMPLANET announces 2021 revenue growth of 58%, under IFRS

2 nov. 2021

IMPLANET announces the divestment of its knee prosthesis range to refocus on its Spine business

12 oct. 2021

IMPLANET reports consolidated revenue of €5.8 million at September 30, 2021 up 34%

23 sept. 2021

Implanet announces the planned divestment of its knee prosthesis to focus on its Spine business

21 sept. 2021

IMPLANET reports an improvement in its 2021 half-year results

6 juil. 2021

IMPLANET announces consolidated revenue of €2.04 million for Q2 2021

22 juin 2021

IMPLANET signs a strategic partnership with ulrich medical for the distribution of its JAZZ implants and the OSD cervical plate

15 juin 2021

IMPLANET signs an exclusive distribution contract for France with GLOBUS MEDICAL

18 mai 2021

IMPLANET announces the implementation of the OSD acquisition

5 mai 2021

Second call of Implanet's AGM on 18 May 2021 at 14:00

20 avr. 2021

Implanet reports Q1 2021 revenue of €1.7 million, driven by the dramatic growth of its Spine activity

15 avr. 2021

Procedures for participating in Implanet's Combined General Meeting of May 5, 2021 at 2 pm CEST

12 avr. 2021

Implanet receives TGA clearance for the MADISON total knee prosthesis in Australia

bottom of page